Best treatments for colonic neoplasms
11 products may treat colonic neoplasms, spanning FDA drug classes such as nucleoside metabolic inhibitor, alkylating drug, topoisomerase inhibitor. The current highest-rated option is tolak. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 11 drugs we list for colonic neoplasms, 4 are available as lower-cost generics, spanning classes such as nucleoside metabolic inhibitor, alkylating drug, topoisomerase inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for colonic neoplasms — so confirm the right choice with your prescriber.
Top-rated picks for colonic neoplasms: 1. Tolak · 2. Gleostine · 3. Gliadel
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Topical | Nucleoside Metabolic Inhibitor | Generic | $1 | View → | |
| 2 | 70/100 | Prescription | Capsule | Alkylating Drug | No data | — | View → | |
| 3 | 70/100 | Prescription | Wafer | Alkylating Drug | No data | — | View → | |
| 4 | 64/100 | Prescription | Injectable | Topoisomerase Inhibitor | No data | — | View → | |
| 5 | Not yet rated | Prescription | Kit | Alkylating Drug | No data | — | View → | |
| 6 | Not yet rated | Prescription | Topical | Nucleoside Metabolic Inhibitor | Generic | $1 | View → | |
| 7 | Not yet rated | Prescription | Injectable | Nucleoside Metabolic Inhibitor | Generic | $1 | View → | |
| 8 | Not yet rated | Prescription | Topical | Nucleoside Metabolic Inhibitor | Generic | $1 | View → | |
| 9 | Not yet rated | Prescription | Injectable | Topoisomerase Inhibitor | No data | — | View → | |
| 10 | Not yet rated | Prescription | Capsule | Alkylating Drug | No data | — | View → |
Narrow by drug class
Explore the class hubs: nucleoside metabolic inhibitor · alkylating drug · topoisomerase inhibitor
Full ranking · 11 treatments
tolak
PrescriptionFDA-sourced
Tolak (Fluorouracil) is a nucleoside metabolic inhibitor used to treat Breast Neoplasms, Basal Cell Carcinoma, Colonic Neoplasms, Head and Neck Neoplasms.
Pharmacy pays
From ~$0.60· 4 formsgleostine
Boxed warningPrescriptionFDA-sourced
Gleostine (Lomustine) is an alkylating drug used to treat Brain Neoplasms, Colonic Neoplasms, Hodgkin Disease, Kidney Neoplasms.
Price varies
gliadel
PrescriptionFDA-sourced
Gliadel (Carmustine) is an alkylating drug used to treat Brain Neoplasms, Carcinoma, Colonic Neoplasms, Ependymoma.
Price varies
camptosar
Boxed warningPrescriptionFDA-sourced
Camptosar (Irinotecan Hydrochloride) is a topoisomerase inhibitor used to treat Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Colonic Neoplasms, Leukemia.
Price varies
bicnu
Boxed warningPrescriptionFDA-sourced
Bicnu (Carmustine) is an alkylating drug used to treat Brain Neoplasms, Carcinoma, Colonic Neoplasms, Ependymoma.
Price varies
efudex
PrescriptionFDA-sourced
Efudex (Fluorouracil) is a nucleoside metabolic inhibitor used to treat Breast Neoplasms, Basal Cell Carcinoma, Colonic Neoplasms, Head and Neck Neoplasms.
Pharmacy pays
From ~$0.60· 4 formsFrequently asked
- What treats colonic neoplasms?
- Our catalog lists 11 products that may treat colonic neoplasms, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is tolak.
- What is the best-rated treatment for colonic neoplasms?
- By our independent recall-safety rating — not an efficacy measure — tolak ranks highest among the products we list for colonic neoplasms. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat colonic neoplasms?
- Treatments for colonic neoplasms span FDA drug classes including nucleoside metabolic inhibitor, alkylating drug, topoisomerase inhibitor. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.